YOLFTbeta
Cell Biotech Co. Ltd

Cell Biotech Co. Ltd

049960 · KQ · Healthcare / Biotechnology & Medical Research

13,650.00KRW+130.00 (+0.96%)

Price History

Full chart

Market Stats

Previous Close13,520.00
Open13,920.00
Day Range13,410.00 – 13,920.00
52-Week Range10,976.37 – 18,500.00
Volume12.78K
Market Cap106.01B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.41%
Beta1.09
50-Day Avg15,440.00
200-Day Avg14,978.60

About

Cell Biotech Co., Ltd., a biotechnology company, develops and sells lactic acid bacteria in South Korea. It also offers probiotic products under the Nutra DUOLAC, LACTOClear, and LAB2PRO brands. The company also exports its products to approximately 40 countries, including the United States, Europe, Japan, and China. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology & Medical Research
  • CEODr. Myung-Jun Jung
  • Employees109
  • Headquarters50, Aegibong-ro 409beon-gil, Gimpo-si, South Korea, Korea
  • Websitehttps://www.cellbiotech.com

Leadership

  • Dr. Myung-Jun JungChief Exec. Officer and Director · b. 1958
  • Mr. Jong Suk ChaExec. Director
  • Mr. Sung-Bae YounManaging Director · b. 1964

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue23.32B25.89B31.60B40.77B49.50B58.28B61.06B62.54B45.96B45.58B46.87B50.53B53.79B49.91B53.13B
Growth (%)-+11.03%+22.05%+29.02%+21.43%+17.72%+4.77%+2.44%-26.52%-0.82%+2.83%+7.79%+6.46%-7.20%+6.44%
Cost of Revenue7.75B8.03B8.91B10.28B11.43B12.79B12.63B13.70B10.75B10.86B11.19B12.57B14.81B13.85B14.50B
Gross Profit-17.12B21.81B29.50B38.08B45.49B48.43B48.84B35.21B34.73B35.68B37.95B38.97B36.06B38.62B
Gross Margin-66.13%69.04%72.37%76.92%78.06%79.32%78.10%76.61%76.18%76.13%75.11%72.46%72.25%72.70%
Operating Expense-10.59B12.42B16.60B19.32B23.93B25.80B27.17B29.41B31.06B28.43B31.88B36.86B29.26B30.71B
Operating Income5.74B6.53B9.39B12.91B18.76B21.56B22.63B21.67B5.79B3.67B7.26B6.07B2.11B6.80B7.91B
Operating Margin24.62%25.24%29.72%31.66%37.89%37.00%37.07%34.66%12.61%8.05%15.48%12.01%3.93%13.62%14.90%
EBITDA-----------13.85B10.85B19.54B14.90B
EBITDA Margin-----------27.41%20.16%39.15%28.05%
Net Income5.20B6.14B7.80B10.40B17.51B18.50B18.20B19.38B7.23B3.19B10.38B8.28B6.30B15.13B10.13B
Net Income Margin22.31%23.72%24.68%25.52%35.36%31.74%29.80%30.99%15.73%7.00%22.15%16.39%11.72%30.31%19.06%
R&D1.53B-1.92B2.06B2.84B2.92B2.89B3.43B3.67B3.33B3.50B3.56B3.72B4.33B3.88B
R&D as % of Total Revenue6.58%-6.06%5.04%5.75%5.01%4.73%5.49%7.99%7.30%7.47%7.04%6.93%8.68%7.31%
Interest Expense0000000058.59M49.28M42.48M37.49M61.95M60.88M32.59M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.13%0.11%0.09%0.07%0.12%0.12%0.06%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets36.75B40.30B46.70B57.60B74.97B90.53B96.48B112.05B108.30B105.30B112.88B115.84B117.64B130.40B136.57B
Total Liabilities4.98B3.88B3.65B5.24B6.21B6.38B6.28B6.42B4.70B5.32B6.19B7.75B5.76B6.23B4.94B
Total Equity31.68B36.42B43.05B52.36B68.76B84.15B90.20B105.62B103.60B99.98B106.69B108.09B111.89B124.17B131.64B
Cash7.99B5.34B4.76B5.39B7.27B10.58B13.61B13.33B9.41B9.59B12.91M7.08M7.88B4.76B17.14B
Total Debt--------512.08M686.44M-----

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.45B6.17B8.99B9.91B18.24B17.99B22.53B13.98B10.23B9.56B14.89B12.81B7.82B19.27B11.11B
Investing Cash Flow--8.42B-7.65B-8.07B-14.97B-11.54B-7.41B-10.14B-4.39B-1.63B-11.13B-6.67B-4.75B-18.74B-
Financing Cash Flow--358.00M-1.96B-1.16B-1.16B-3.09B-11.91B-4.14B-9.62B-7.62B-3.86B-7.54B-3.72B-3.74B-
Capital Expenditure580.85M3.36B6.31B1.38B3.38B2.16B5.36B7.11B9.47B3.08B848.59M2.67B1.69B1.28B3.21B
Free Cash Flow---------6.47B13.93B10.14B6.13B17.99B7.90B
Dividends Paid1.16B1.16B1.16B1.16B1.16B3.09B4.25B4.13B4.50B4.34B3.18B3.18B3.08B3.08B3.08B
FCF to OCF---------67.66%93.51%79.14%78.42%93.35%71.15%
Dividend Paid to FCF---------67.08%22.85%31.38%50.25%17.12%38.97%

Earnings

Report DateMar 31, 2011Jun 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013May 28, 2014Sep 3, 2014Nov 3, 2014Feb 3, 2015Apr 30, 2015Jul 22, 2015Oct 16, 2015Feb 18, 2016Apr 27, 2016Aug 7, 2016Nov 3, 2016Feb 9, 2017May 10, 2017Aug 9, 2017Nov 7, 2017Feb 13, 2018May 9, 2018Aug 9, 2018Nov 8, 2018Feb 15, 2019May 9, 2019Aug 8, 2019Nov 7, 2019Feb 14, 2020May 14, 2020Aug 7, 2020Nov 9, 2020Feb 19, 2021May 7, 2021Aug 8, 2021Nov 2, 2021Feb 14, 2022May 10, 2022Aug 8, 2022Nov 7, 2022Feb 16, 2023May 10, 2023Aug 4, 2023Nov 8, 2023Mar 27, 2024May 8, 2024Aug 6, 2024Nov 6, 2024Feb 19, 2025May 9, 2025Aug 4, 2025Nov 4, 2025Dec 31, 2025May 7, 2026Jun 30, 2026
EPS Estimate---------------------574.00489.58484.90597.26527.49525.74-506.45598.38558.27------------------------------
EPS Actual127.00175.31140.98173.53236.11224.89142.5285.89295.52245.60383.33241.16280.02381.63444.69224.10557.81913.82564.22632.88624.82397.00665.00451.00922.00655.00389.00674.61664.00520.00724.00294.00269.00228.91174.26423.6967.37158.57-201.09390.33114.00550.00414.26414.26460.01802.29-497.69417.39-324.49432.71395.46476.51589.88141.601002.25302.4331.19503.95641.88781.98526.91
Surprise----------------------30.84%35.83%-6.99%54.37%24.17%-26.01%-31.11%-13.10%29.69%------------------------------
Timing-------------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap106.01B
Enterprise Value5.89B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.69
Price / Book0.75
Revenue (TTM)48.75B
Gross Profit (TTM)35.47B
EBITDA10.50B
Profit Margin30.03%
Operating Margin14.06%
Return on Equity1184.94%
Return on Assets3.72%
Shares Outstanding7.72M
Shares Float4.49M
Beta1.09
Dividend Yield3.41%
Dividend Rate0.00
Payout Ratio24.44%

Dividends

20251×
600.00Dec 29, 2025
20241×
450.00Dec 27, 2024
20231×
450.00Dec 27, 2023
20221×
450.00Dec 28, 2022
20211×
450.00Dec 29, 2021
20201×
450.00Dec 29, 2020
20191×
600.00Dec 27, 2019
20181×
600.00Dec 27, 2018
20171×
550.00Dec 27, 2017
20161×
550.00Dec 28, 2016
20151×
400.00Dec 29, 2015
20141×
150.00Dec 29, 2014
20131×
150.00Dec 27, 2013
20121×
150.00Dec 27, 2012
20111×
150.00Dec 28, 2011
20101×
150.00Dec 29, 2010
20091×
100.00Dec 29, 2009
20081×
100.00Dec 29, 2008
20071×
100.00Dec 27, 2007

Stock Splits

  • Jul 14, 20051117:1014